上海医药：目前公司整体运营规范有序，各项业务稳步推进

Group 1 - The core viewpoint of the article is that Shanghai Pharmaceuticals (601607) is currently operating in an orderly manner, with steady progress in various business segments and stable performance [1] Group 2 - The company has responded to investor inquiries on its interactive platform, indicating confidence in its overall operations [1] - Business operations are reported to be advancing steadily, suggesting a positive outlook for future performance [1] - The company's performance is described as stable, which may indicate resilience in its financial results [1]